Skip to content

Comparison of the effect of absorbable suture and non-absorbable suture on postoperative recurrence rate in the excision of keloid and hypertrophic scar

Comparison of the effect of absorbable suture and non-absorbable suture on postoperative recurrence rate in the excision of keloid and hypertrophic scar

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037712
Enrollment
Unknown
Registered
2020-08-30
Start date
2020-09-30
Completion date
Unknown
Last updated
2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid and hypertrophic scar

Interventions

A:using vircyl suture material
B:using prolene suture material

Sponsors

Department of Plastic Surgery and Burns, North Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-50 years; 2. Patients with keloids or hypertrophic scars with clear indications for surgery; 3. Patients with keloid without any form of treatment before enrollment; 4. Patients without diseases affecting the healing of surgical incision, such as septicemia, osteogenesis imperfecta, Ehlers Danlos syndrome, etc; 5. Patients without severe diseases of the center of gravity, liver, kidney and blood system; 6. The patient has signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who need long-term outdoor work; 2. Patients with diseases affecting wound healing, such as pernicious disease, osteogenesis imperfecta, Ehlers Danlos syndrome, etc; 3. Patients with severe heart, liver and kidney dysfunction, diabetes and other diseases; 4. Patients with mental illness, including severe hysteria, do not have autonomy; 5. Patients who are allergic or intolerant to the sutures and drugs used; 6. Patients who have participated in other clinical trials in the last three months; 7. Patients with any medical history may interfere with the experimental results or increase the risk of patients according to the judgment of the researchers; 8. The researcher judged the patients who had poor compliance and could not strictly implement the protocol.

Design outcomes

Primary

MeasureTime frame
recurrence rate;

Countries

China

Contacts

Public ContactPingsong Li

North Jiangsu People's Hospital

840734786@qq.com+86 13338846588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026